tweetindex
TR

ACS Publications Bio & Med Chem Content

@ACSBioMed · joined 23 Nov 2011

Journal articles, eBooks, news, events, and other information about biological and medicinal chemistry from @ACSPublications, a division of @AmerChemSociety

15 807Followers
394Following
4 406Posts total
2.9KViews on collected posts

Son gönderiler

Why do some PROTACs show incomplete target degradation? In this @ACSPublications article, the authors reveal that protein age matters: older proteins are degraded more efficiently than newly synthesized ones. #ACSChemBio https://t.co/yREJTsO7Fl https://t.co/9kcfL7Fgq3
579 views · 7 likes · 1 reposts · 0 replies Open on X →
We're excited to announce our speakers at the upcoming ACS150 #JACS Symposium Series: @UCT_news, celebrating 150 years of the @AmerChemSociety and chemical discovery. 📅 10-11 September 🔗 Apply to attend this free event: https://t.co/ydO7gaFNmN https://t.co/hqFUBymQLI
574 views · 3 likes · 1 reposts · 0 replies Open on X →
Call For Papers: Medicinal Chemistry and Pharmacology of Antiviral Drugs This joint Special Issue will showcase breakthroughs in combating viral resistance, persistent infections, and emerging viral threats. Submit your manuscript by January 31, 2027: https://t.co/jOl7sTi0S4 ht
527 views · 3 likes · 1 reposts · 0 replies Open on X →
ACS editors guide the world’s leading chemistry journals, helping discoveries shape the future of science. Join our global forum – submit your manuscript: https://t.co/AbkhnAUJOQ https://t.co/gDaUJfCLHf
571 views · 2 likes · 1 reposts · 0 replies Open on X →
@ACSBioMed Hey, looks like the latest issue of Bio # Med Chem is live and I just might have to dive in !. 12 views · 0 likes · 0 reposts · 0 replies Open on X →
New issue alert! 📣 The latest issue of #ACSBioMedChemAu is now live. Explore the newest open access research in biomedical and medicinal chemistry: https://t.co/PI7EyutwT4 https://t.co/zLUMPFhMFW
609 views · 1 likes · 0 reposts · 1 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 6 gönderi, 10K–100K takipçi aralığıyla yan yana. boyutuna göre olağan erişim, çoğundan daha zayıf tepki.

Medyan görüntülenme572bu hesap92710K–100K için medyan
Erişim, %3.62%bu hesap3.63%10K–100K için medyan
Etkileşim, %0.61%bu hesap1.52%10K–100K için medyan
ÖlçütBu hesap10K–100K için medyanOran
Gönderi başına medyan görüntülenme5729270.62×
Erişim (görüntülenme ÷ takipçi)3.62%3.63%1.00×
Etkileşim oranı0.61%1.52%0.40×

Bu aralıktaki diğer hesaplar →   Başka bir hesapla karşılaştır →   Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

60928 Aug
12
57130 Aug
5271 Sep
5743 Sep
579

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.33%28 Aug
0.00%
0.53%30 Aug
0.76%1 Sep
0.70%3 Sep
1.38%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes59.3%16 in total
Reposts14.8%4 in total
Replies3.7%1 in total
Bookmarks22.2%6 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Benzer hesaplar